论文部分内容阅读
目的 :了解 C反应蛋白对不稳定型心绞痛及其支架置入术的影响。方法 :选择 2 0 0 2年 9月～ 2 0 0 4年 1月 ,因不稳定型心绞痛行冠状动脉造影术的患者 1 9例 ( 组 )和非心绞痛行冠状动脉造影术的患者 32例 ( 组 ) ,观察两组冠状动脉造影结果 ,及不稳定型心绞痛冠状动脉血管成形术及支架置入术前后的 CRP、CK- MB、CK、Tn I的差异。结果 :两组 C反应蛋白水平分别为 ( 5 .5 0±1 .0 7) mg/L和 ( 3.76± 0 .74) mg/L,两组比较 ,P<0 .0 1 ; 组血管成形术和支架置入术前后的 RP水平差值为 ( 1 .36± 1 .0 8) mg/L,前后比较 P<0 .0 1。结论 :C反应蛋白对不稳定型心绞痛的早期决策有临床意义 ,并对支架治疗不稳定型心绞痛疗效的评判有一定的参考价值。
Objective: To understand the impact of C-reactive protein on unstable angina and stent placement. Methods: From September 2002 to January 2004, 19 patients undergoing coronary angiography (UA) and 32 patients undergoing non-angina pectoris underwent coronary angiography Group). The difference of CRP, CK-MB, CK, Tn I before and after coronary angioplasty and stent implantation in both groups were observed. Results: The levels of C-reactive protein in the two groups were (5.5 ± 1.07) mg / L and (3.76 ± 0.74) mg / L respectively, P <0.01; The difference of RP level before and after operation and stent implantation was (1.36 ± 1.08) mg / L before and after P <0.01. CONCLUSION: C-reactive protein is of clinical significance in the early decision-making of unstable angina pectoris and has certain reference value for the evaluation of the efficacy of scaffold in the treatment of unstable angina pectoris.